ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low

November 9, 1979

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997